Drawing for APLUSA

USPTO serial 79388334

APLUSA

Reviewed by CopyMark Law Group

Reg. 7734362Status 700Registered
Filing date
Status date
Registration date
Mar 25, 2025
Examiner
CREEF, DAVIS W
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with APLUSA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary Margaret L. O'Donnell

Mary Margaret L. O'Donnell Blue Filament Law PLLC700 E. Maple RoadSuite 450Birmingham, MI 48009

Goods and services

ClassDescriptionStatusFirst use
035Business advisory services for marketing, market research and analysis, commercial surveys, qualitative and quantitative commercial studies, commercial investigations, collection of commercial information as well as consumer opinions and behavior in the context of market research and customer satisfaction surveys, computer file management and database management, all these services being carried out for industrialists in the pharmaceutics, biology and biomedical sectors, as well as for institutions and businesses engaged in the field of health issues; commercial data analysis and formatting services, namely, business data analysis of the results of commercial surveys, commercial studies, market research, for the benefit of industrialists in the pharmaceutics, biology and biomedical sectors, as well as for institutions or businesses engaged in the field of health issuesACTIVE—
041Editing services of data collected in the context of market research and analysis, commercial surveys, qualitative and quantitative commercial studies, commercial and customer satisfaction surveys carried out for industrialists in the pharmaceutics, biology and biomedical sectors, as well as for institutions or businesses engaged in the field of health issues; publishing of electronic books, electronic publications, online publications, printed brochures and booklets, featuring scientific and commercial data and information collected from market research and analysis, commercial surveys, qualitative and quantitative commercial studies, commercial investigations and customer satisfaction surveys carried out for industrialists in the pharmaceutics, biology and biomedical sectors, as well as for institutions and businesses engaged in the field of health issues; services for the arranging and conducting of educational congresses, colloquiums, symposiums and conferences in the field of training in market study and analysis methodology, commercial surveys, qualitative and quantitative commercial studies, commercial investigations, collection of commercial information as well as consumer opinions and behavior in the context of market research and customer satisfaction surveys, all these services being carried out for industrialists in the pharmaceutics, biology and biomedical sectors, as well as for institutions or businesses engaged in the field of health issuesACTIVE—
042Design and development services for others of software and methods adapted for conducting, processing and analysis of market research, commercial surveys and commercial investigations for industrialists in the pharmaceutics, biology and biomedical sectors, as well as for institutions or businesses engaged in the field of health issues; industrial research in the field of pharmaceutics, biology and health and new product design services for industrialists in the pharmaceutics, biology and biomedical sectors, as well as for institutions or businesses engaged in the field of health issuesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 4, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 4, 2025FIMPFINAL DISPOSITION PROCESSED—
Jul 18, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 1, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 1, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 25, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 8, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 25, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 25, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 9, 2024DOCKASSIGNED TO EXAMINER—
Nov 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 24, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 24, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 24, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 24, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 17, 2024RFNTREFUSAL PROCESSED BY IB—
May 24, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 23, 2024RFRRREFUSAL PROCESSED BY MPU—
May 14, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 13, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2024DOCKASSIGNED TO EXAMINER—
Feb 6, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 2, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 1, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance